Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

Objective: Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8–10 hours, and thereafter, provide a control...

Descripción completa

Detalles Bibliográficos
Autores principales: Pliszka, Steven R., Wilens, Timothy E., Bostrom, Samantha, Arnold, Valerie K., Marraffino, Andrea, Cutler, Andrew J., López, Frank A., DeSousa, Norberto J., Sallee, Floyd R., Incledon, Bev, Newcorn, Jeffrey H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567875/
https://www.ncbi.nlm.nih.gov/pubmed/29172680
http://dx.doi.org/10.1089/cap.2017.0084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567875/
https://www.ncbi.nlm.nih.gov/pubmed/29172680
http://dx.doi.org/10.1089/cap.2017.0084

Ejemplares similares